EUVIMEDEUVIMED entdecken
Open Access · CC BY-ND 4.0

Application of Design of Expert software for evaluating the influence of formulation variables on the encapsulation efficacy, drug content and particle size of PEO-PPO-PEO/Poly(DL-lactide-co-caprolactone) nanoparticles as carriers for SN-38

Rozafa Koliqi, Pranvera Breznica, Arlinda Daka, Blerina Koshi

Medicine and Pharmacy Reports · 30.11.2021 · 94 (4) · 483-497

DOI: 10.15386/mpr-1831 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicine and Pharmacy Reports, online erschienen am 30.11.2021. Verfasst von Rozafa Koliqi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Biopharmacy, Pharmacy Division, Faculty of Medicine, University "Hasan Prishtina", Prishtina, Republic of Kosovo. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims. Hydrophobic substances are mainly encapsulated into polymer nanocarriers in order to improve their solubility, enable their administration, at the same time to empower targeted tissue or cell specific delivery of the drug using the encapsulating vehicle as targeting and controlled release platform. 7-Ethyl-10-hydroxycamptothecin (SN-38) is an active metabolite of Irinotecan, showing 100- fold to 1000-fold higher effect than Irinotecan, but its clinical use is limited because of its extreme hydrophobicity, as it is practically insoluble in most physiologically compatible and pharmaceutically acceptable solvents.

Method

In order to fully exploit the potential of the nanoprecipitation as a method for preparation of Poly(DL-lactide-co-caprolactone)- poly(ethylene oxide) - poly(propylene oxide) - poly(ethylene oxide) (P(DL)LCL/PEO-PPO-PEO) nanoparticles and evaluate the influence of the polymer P(DL)LCL, stabilizing agent PEO-PPO-PEO copolymer (Lutrol F127) and the drug concentration (SN-38) upon drug entrapment efficiency, size and drug content, a D-optimal experimental design for response surface using Design Expert Version 9.0.4.1. software investigation was created and statistically analyzed.

Results

We have observed that at higher SN-38 concentration during the preparation procedure (nanoprecipitation, solvent diffusion method), and due to its extremely low water solubility, the drug will start to precipitate as unprotected crystals at a faster pace compared to polymer aggregation, leading to extremely low encapsulation efficacy and waste of the active compound. The most desirable combination of factor settings are SN-38=0.5 mg, Polymer=5mg and F127=4%.

Conclusion

This investigation utilizes the design of experiment approach and extends the primary understanding of impact of formulation development of P(DL)LCL/PEO-PPO-PEO nanoparticles as carriers for SN-38.

Schlagwörter

Stichwörter der Autor:innen

IrinotecanP(DL)LCL nanoparticlesSN-38hydrophobic and hydrophilic interactionsnanocarriersresearch design

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Biopharmacy, Pharmacy Division, Faculty of Medicine, University "Hasan Prishtina", Prishtina, Republic of Kosovo.
  • Department of Pharmaceutical Chemistry, Pharmacy Division, Faculty of Medicine, University "Hasan Prishtina", Prishtina, Republic of Kosovo.
  • Department of Pharmaceutical Technology and Drug Control, Pharmacy Division, Faculty of Medicine, University "Hasan Prishtina", Prishtina, Republic of Kosovo.

Zitieren

APA

Koliqi, R., Breznica, P., Daka, A., & Koshi, B. (2021). Application of Design of Expert software for evaluating the influence of formulation variables on the encapsulation efficacy, drug content and particle size of PEO-PPO-PEO/Poly(DL-lactide-co-caprolactone) nanoparticles as carriers for SN-38. Medicine and Pharmacy Reports, 94(4), 483-497. https://doi.org/10.15386/mpr-1831

Vancouver

Koliqi R, Breznica P, Daka A, Koshi B. Application of Design of Expert software for evaluating the influence of formulation variables on the encapsulation efficacy, drug content and particle size of PEO-PPO-PEO/Poly(DL-lactide-co-caprolactone) nanoparticles as carriers for SN-38. Medicine and Pharmacy Reports. 2021;94(4):483-497. doi:10.15386/mpr-1831

BibTeX
@article{Koliqi2021,
  author = {Koliqi, Rozafa and Breznica, Pranvera and Daka, Arlinda and Koshi, Blerina},
  title = {Application of Design of Expert software for evaluating the influence of formulation variables on the encapsulation efficacy, drug content and particle size of PEO-PPO-PEO/Poly(DL-lactide-co-caprolactone) nanoparticles as carriers for SN-38},
  journal = {Medicine and Pharmacy Reports},
  year = {2021},
  volume = {94},
  number = {4},
  pages = {483--497},
  doi = {10.15386/mpr-1831}
}
Kostenlos starten →